Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page history now shows a new release note: Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T22:02:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page history now includes a new Revision: v3.3.2 entry and appears to remove the previous Revision: v3.3.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:48:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.1 to reflect the latest revision. No study data, navigation, or page functionality are affected.
    Difference
    0.1%
    Check dated 2025-11-24T12:15:13.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The government funding/operating status notice at the bottom of the page was removed. This administrative change does not alter the study information or how users interact with the record.
    Difference
    0.5%
    Check dated 2025-11-17T06:22:39.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T00:58:43.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Updated operating status notice and newer versioning information; removed previous revision/date, indicating a shift to current status and version v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T09:21:31.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.